Home / Insights / Biotech ImmVirX bucks VC desert to bank raise at $75m valuation

Biotech ImmVirX bucks VC desert to bank raise at $75m valuation

Read the full article: Australian Financial Review

10 June 2023

Posted in — Healthcare, News

Share
Share

You may also like

18 June 2023

Healthcare

Vaxxas opens world-class manufacturing facility to produce needle-free vaccine patch


06 December 2022

Healthcare

Needle-free vaccine innovator banks $34m


10 November 2021

Healthcare

Vaxxas recognised in the Top 10 healthcare startups in Australia, 2021


View All

Ventured. Gained.
decor